SCHEMBL4562282

SCHEMBL4562282

CSc1nccn2cccc12

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KLK7 P49862 1/20 0.34
DRD1 P21728 1/20 0.32
ACKR3 P25106 1/20 0.32
KMT2A Q03164 2/20 0.31
RAB9A P51151 1/20 0.31
HTR6 P50406 1/20 0.31
TSHR P16473 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
RPS6KA5 O75582 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9772459 0.74 PTGS2 (0.38) KDM4EALDH1A1GAARAB9A
SCHEMBL8829202 0.74 KDM4E (0.41) KDM4EALDH1A1GAAHPGDKLK7
SCHEMBL13178571 0.73 KDM4E (0.34) KDM4EALDH1A1GAAHPGDKLK7
SCHEMBL9772506 0.73 ALDH1A1 (0.47) KDM4EALDH1A1GAAHPGDKMT2A
SCHEMBL103804 0.71 NUDT1 (0.46) KMT2AHTR6
SCHEMBL15760248 0.71 ALDH1A1 (0.35) KDM4EALDH1A1GAAHPGDKLK7
SCHEMBL14725911 0.70 GRM5 (0.49) KDM4EALDH1A1GAAHPGDKLK7
SCHEMBL8858892 0.70 GRM5 (0.36) KDM4EALDH1A1GAAHPGDRAB9A
SCHEMBL397662 0.69 NUDT1 (0.50) KDM4EALDH1A1GAAHPGDKLK7
SCHEMBL3042386 0.69 KDM4E (0.33) KDM4EALDH1A1GAAHPGDKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed
WO-1997003055-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING REPLICATION OF RETROVIRUSES AND FOR INHIBITING TUMOR PROMOTER INITIATED TRANSCRIPTION SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1997-01-30 WO disclosed